TrialThe oncologist2020

An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.

Aleksei Viktorovich Novik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.